These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 8902150

  • 1. The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia.
    Joven J, Espinel E, Simó JM, Vilella E, Camps J, Oliver A.
    Atherosclerosis; 1996 Oct 25; 126(2):243-52. PubMed ID: 8902150
    [Abstract] [Full Text] [Related]

  • 2. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD, Stroes ES, Willekes-Koolschijn N, Rabelink TJ, Koomans HA, Joles JA.
    Kidney Int; 1999 Mar 25; 55(3):1005-10. PubMed ID: 10027937
    [Abstract] [Full Text] [Related]

  • 3. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C.
    Clin Chem; 1995 Jun 25; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [Abstract] [Full Text] [Related]

  • 4. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M, Salamatullah Q, Ferdous Z, Hussain MA.
    Bangladesh Med Res Counc Bull; 1976 Jun 25; 2(1):64-70. PubMed ID: 190998
    [Abstract] [Full Text] [Related]

  • 5. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
    Kaysen GA.
    Miner Electrolyte Metab; 1992 Jun 25; 18(2-5):212-6. PubMed ID: 1465061
    [Abstract] [Full Text] [Related]

  • 6. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity.
    Appel GB, Blum CB, Chien S, Kunis CL, Appel AS.
    N Engl J Med; 1985 Jun 13; 312(24):1544-8. PubMed ID: 3858668
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?
    Chan MK, Persaud JW, Ramdial L, Varghese Z, Sweny P, Moorhead JF.
    Clin Chim Acta; 1981 Dec 24; 117(3):317-23. PubMed ID: 7318185
    [Abstract] [Full Text] [Related]

  • 9. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J, Vilella E.
    Clin Nephrol; 1997 Sep 24; 48(3):141-5. PubMed ID: 9342484
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome.
    de Zeeuw D, Gansevoort RT, Dullaart RP, de Jong PE.
    J Hypertens Suppl; 1995 Jul 24; 13(1):S53-8. PubMed ID: 18800457
    [Abstract] [Full Text] [Related]

  • 11. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis.
    Kaysen GA, Jones H, Joles JA, van Tol A.
    Miner Electrolyte Metab; 1996 Jul 24; 22(1-3):31-8. PubMed ID: 8676821
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis.
    Sun X, Jones H, Joles JA, van Tol A, Kaysen GA.
    Am J Physiol; 1992 May 24; 262(5 Pt 2):F755-61. PubMed ID: 1590420
    [Abstract] [Full Text] [Related]

  • 13. Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.
    Noto D, Barbagallo CM, Cascio AL, Cefalù AB, Cavera G, Caldarella R, Marino G, Travali S, Cutaia I, Maringhini S, Notarbartolo A, Averna M.
    Kidney Int; 1999 Jun 24; 55(6):2433-9. PubMed ID: 10354292
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma protein synthesis in patients with low-grade nephrotic proteinuria.
    Zanetti M, Barazzoni R, Garibotto G, Davanzo G, Gabelli C, Kiwanuka E, Piccoli A, Tosolini M, Tessari P.
    Am J Physiol Endocrinol Metab; 2001 Apr 24; 280(4):E591-7. PubMed ID: 11254466
    [Abstract] [Full Text] [Related]

  • 17. Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome.
    Tarugi P, Nicolini S, Albertazzi L, Calandra S, Salvati P, Ferti C, Patrono C.
    J Lipid Res; 1991 Oct 24; 32(10):1675-87. PubMed ID: 1797947
    [Abstract] [Full Text] [Related]

  • 18. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M.
    N Engl J Med; 1990 Aug 30; 323(9):579-84. PubMed ID: 2381443
    [Abstract] [Full Text] [Related]

  • 19. A simultaneous study of the metabolism of apolipoprotein B and albumin in nephrotic patients.
    Demant T, Mathes C, Gütlich K, Bedynek A, Steinhauer HB, Bosch T, Packard CJ, Warwick GL.
    Kidney Int; 1998 Dec 30; 54(6):2064-80. PubMed ID: 9853272
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P, Lu L, Hu B, Du PF.
    Scand J Clin Lab Invest; 2009 Dec 30; 69(6):680-6. PubMed ID: 19468931
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.